<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04218812</url>
  </required_header>
  <id_info>
    <org_study_id>PROMAESIS</org_study_id>
    <nct_id>NCT04218812</nct_id>
  </id_info>
  <brief_title>Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation</brief_title>
  <acronym>PROMAESIS</acronym>
  <official_title>Prospective Multicenter Study on Localization Accuracy and Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation( PROMAESIS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sándor Beniczky</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Epilepsy Center, Dianalund,Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital del Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brno Epilepsy Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Bucharest (Adult)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Freiburg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kepler University Clinic, Linz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Motol University Hospital, Prague</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Christian Doppler Klinik, Salzburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Hospitalar e Universitário de Coimbra, E.P.E.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Valencia University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carlo Besta Institure, Milano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital de Santa Maria, Lisbon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Electrical source imaging is part of the presurgical evaluation of patients with
      drug-resistant focal epilepsy. The software packages that will be used in this study have
      Declaration of Conformity within the European Economic Area (CE mark) for this specific
      medical use. In spite of being part of the clinical standard, the evidence for the accuracy
      and clinical utility of these methods are derived from several smaller-scale and
      retrospective studies. The PROMAESIS study will provide solid evidence of the accuracy and
      clinical utility of automated ESI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One-third of patients with epilepsy have seizures resistant to pharmacotherapy. There are
      many approaches developed to control these seizures, yet epilepsy surgery is still the most
      common method. The crucial part of epilepsy surgery is to assess the epileptic zone in order
      to render patients seizure free. However, accurate localization of the epileptic zone is
      often challenging due to the multimodal approach. This contains semiology, EEG (obtained
      during long term video-EEG monitoring), magnetic resonance Imaging (MRI), in addition to
      certain cases, positron emission computed tomography (PET), and single photon emission
      computed tomography (SPECT) and magnetoencephalography (MEG). At present, in one of the third
      patients, seizure remains after epilepsy surgery. Therefore a new preoperative method should
      be improved to assess the epileptic zone. Automated ESI is a post-processing novel method
      that estimates the location in the brain of the source of the recorded EEG signals.

      The objective of this study is:

        1. To determine the accuracy of ESI in localizing the epileptic focus.

        2. To determine the clinical utility of ESI on clinical decision making

      Methods:

      Study design: a prospective diagnostic study in line with the Standards for Reporting
      Diagnostic Accuracy Studies (STARD).

      EEG was recorded using the International Federation of Clinical Neurophysiology (IFCN)
      electrode array of 25 electrodes including six electrodes in the Inferior temporal chain
      (F9/10, T9/10, and P9/10) in addition to the 19 electrodes of the 10-20 system. Electrode
      impedance was kept below 5 kilo-ohm. EEG was recorded with a sampling frequency of 256 Hz.
      The investigators will make a video on how to place the electrodes, to make sure all centers
      follow a standardized method. Multidisciplinary epilepsy teams classify that in the first
      step you should keep the multidisciplinary team blinded to the source imaging data, and make
      the implantation plan without the ESI results. Then show the ESI, adjust the plan and note
      the changes.

      The multidisciplinary teams in different centers will classify seizures into &quot;types.&quot; A
      seizure type is a group of seizures that have stereotypical semiology and ictal EEG. Maximum
      3 seizures are registered for per type. After Long Term Monitoring, they provide Epilog and
      Brain Electrical Source Analysis (BESA) teams with datasets including MRI and Long Term
      Monitoring recording for each patient. For uploading datasets, multicenter teams will use the
      platform developed by Epilog. Afterward, Epilog and BESA teams (blinded to patient
      information) will run the automated source imaging-both for interictal epileptiform discharge
      (EDs) and ictal signs. Both software packages have CE mark for ESI. Finally, the
      multidisciplinary teams take decisions in two steps:

      I. Considering all data, except ESI II. Adding ESI to all other data.

      At each step, the decisions are classified into one of the following categories:

        1. Stop (operation not recommended)

        2. Implantation of intracranial electrodes

        3. Operation

      In addition, the changes are classified into one of the following categories:

        1. No change - but concordant with the decision.

        2. No change - but discordant with decision.

        3. Change from stop to implantation.

        4. Change from implantation to stop.

        5. Change in implantation plan: implantation of additional sites (besides the ones planned
           in step-1).

        6. Change from implantation of operation.

        7. Change from operation to implantation.

        8. Other (specify in free text). If changes are not related to all analyses results, it
           will be noted, which method(s) triggered the change (SLORETA-interictal / ictal;
           Equivalent Current Dipole - interictal/ictal; CLARA interictal/ictal).

      At one-year follow-up, the changes are categorized as useful or not useful. A change is
      defined useful as follows: (a) change from stop to Intracranial Recording: the Intracranial
      Recording localized the source; (b) change in implantation strategy: the electrode(s)
      implanted based on the source imaging identified the source; (c) change from implantation to
      operation: the patient became seizure-free.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Evaluation of automated electrical source imaging(ESI) in epilepsy surgery.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Sensitivity and Specificity of automated ESI in presurgical evaluation.</measure>
    <time_frame>2 Years</time_frame>
    <description>For determining the the accuracy (sensitivity and specificity) of automated ESI, one year outcome after the operation will be calculated based on the defined criteria.
True Positive (TP): source is in the same sub-lobar region as the resection, seizure-free outcome
False Positive (FP): source is in the same sub-lobar region as the resection, not seizure-free outcome
True Negative (TN): source outside the sub-lobar region that was resected, not seizure-free outcome
False Negative (FN): source outside the sub-lobar region that was resected, seizure-free outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the clinical utility of ESI in management of the patient with medically refractory epilepsy</measure>
    <time_frame>2 years</time_frame>
    <description>For determining the clinical utility, the percentage of patients in whom automated ESI change decision on patients management will be calculated.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Electroencephalography</condition>
  <condition>Refractory Epilepsy</condition>
  <condition>Brain Imaging</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>No electrical source imaging (ESI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The multidisciplinary teams take decisions based on considering all data without ESI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Automated Electrical source imaging (ESI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The multidisciplinary teams take decisions based on considering all data with ESI</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>No electrical source imaging (ESI)</intervention_name>
    <description>For all patients: MRI, semiology, visual interpretation of EEG, and in selected cases, PET, SPECT</description>
    <arm_group_label>Automated Electrical source imaging (ESI)</arm_group_label>
    <arm_group_label>No electrical source imaging (ESI)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Automated electrical source imaging (ESI)</intervention_name>
    <description>The automated source imaging consists of 2 phases
Automated detection of EDs
Source imaging of each spike cluster and seizure onset epoch.</description>
    <arm_group_label>Automated Electrical source imaging (ESI)</arm_group_label>
    <arm_group_label>No electrical source imaging (ESI)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with drug resistant focal epilepsy, admitted to Epilepsy Monitoring Unit for
             presurgical evaluation, who are afterwards discussed at the multidisciplinary epilepsy
             surgery team meetings.

        Exclusion Criteria:

          -  Patients who did not have a seizure during the monitoring.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Rocamora, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital del Mar</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Pali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brno Epilepsy Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ioana Mindruta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Bucharest (Adult)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andreas Schulze Bonhage, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Freiburg University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tim von Oertzen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kepler University Clinic, Linz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vdym Gnatkovsky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carlo Besta Institure, Milano</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Marusic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Motol University Hospital, Prague</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Leitinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christian Doppler Klinik, Salzburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francisco Sales, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Hospitalar e Universitário de Coimbra, E.P.E.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>vicente villanueva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Valencia University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carla Bente, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Santa Maria,</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandor Beniczky, PhD, MD</last_name>
    <phone>+45 5827 1185</phone>
    <email>sbz@filadelfia.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mustafa Aykut Kural, MD</last_name>
    <phone>+45 2481 1885</phone>
    <email>mustafaaykutkural@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kepler University Clinic</name>
      <address>
        <city>Linz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim von Oertzen</last_name>
      <email>Tim.vonOertzen@kepleruniklinikum.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christian Doppler Klinik</name>
      <address>
        <city>Salzburg</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Leitinger, MD</last_name>
      <email>ma.leitinger@salk.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Motol University Hospital</name>
      <address>
        <city>Prague</city>
        <state>Czech Rebuplic</state>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Marusic, MD</last_name>
      <email>Petr.Marusic@fnmotol.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brno Epilepsy Center</name>
      <address>
        <city>Brno</city>
        <state>Czech Republic</state>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Pali, MD</last_name>
      <email>martin.pail@fnusa.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Danish Epilepsy Center</name>
      <address>
        <city>Dianalund</city>
        <zip>DK 4293</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandor Beniczky, PhD,MD</last_name>
      <phone>+45 5827 1192</phone>
      <email>sbz@filadelfia.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Freiburg University</name>
      <address>
        <city>Freiburg</city>
        <state>Baden-Wurttemberg</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Schulze Bonhage, MD</last_name>
      <email>andreas.schulze-bonhage@uniklinik-freiburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carlo Besta Institure</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vdym Gnatkovsky, MD</last_name>
    </contact>
    <contact_backup>
      <email>Vadym.Gnatkovsky@istituto-besta.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Valencia University Hospital</name>
      <address>
        <city>Venice</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>vicente villanueva, MD</last_name>
      <email>vevillanuevah@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar e Universitário de Coimbra</name>
      <address>
        <city>Coimbra</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Sales, MD</last_name>
      <email>fsales5016@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Maria</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Bentes, MD</last_name>
      <email>ccbentes@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Bucharest</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ioana Mindruta, MD</last_name>
      <email>ioanamindruta@me.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Rocamora, MD</last_name>
      <email>99151@parcdesalutmar.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Boon P, D'Havé M, Vanrumste B, Van Hoey G, Vonck K, Van Walleghem P, Caemaert J, Achten E, De Reuck J. Ictal source localization in presurgical patients with refractory epilepsy. J Clin Neurophysiol. 2002 Oct;19(5):461-8.</citation>
    <PMID>12477991</PMID>
  </reference>
  <reference>
    <citation>Brodbeck V, Spinelli L, Lascano AM, Wissmeier M, Vargas MI, Vulliemoz S, Pollo C, Schaller K, Michel CM, Seeck M. Electroencephalographic source imaging: a prospective study of 152 operated epileptic patients. Brain. 2011 Oct;134(Pt 10):2887-97. doi: 10.1093/brain/awr243.</citation>
    <PMID>21975586</PMID>
  </reference>
  <reference>
    <citation>Beniczky S, Lantz G, Rosenzweig I, Åkeson P, Pedersen B, Pinborg LH, Ziebell M, Jespersen B, Fuglsang-Frederiksen A. Source localization of rhythmic ictal EEG activity: a study of diagnostic accuracy following STARD criteria. Epilepsia. 2013 Oct;54(10):1743-52. doi: 10.1111/epi.12339. Epub 2013 Aug 14.</citation>
    <PMID>23944234</PMID>
  </reference>
  <reference>
    <citation>Mégevand P, Spinelli L, Genetti M, Brodbeck V, Momjian S, Schaller K, Michel CM, Vulliemoz S, Seeck M. Electric source imaging of interictal activity accurately localises the seizure onset zone. J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):38-43. doi: 10.1136/jnnp-2013-305515. Epub 2013 Jul 30.</citation>
    <PMID>23899624</PMID>
  </reference>
  <reference>
    <citation>Rikir E, Koessler L, Gavaret M, Bartolomei F, Colnat-Coulbois S, Vignal JP, Vespignani H, Ramantani G, Maillard LG. Electrical source imaging in cortical malformation-related epilepsy: a prospective EEG-SEEG concordance study. Epilepsia. 2014 Jun;55(6):918-32. doi: 10.1111/epi.12591. Epub 2014 Apr 4.</citation>
    <PMID>24702598</PMID>
  </reference>
  <reference>
    <citation>Lascano AM, Perneger T, Vulliemoz S, Spinelli L, Garibotto V, Korff CM, Vargas MI, Michel CM, Seeck M. Yield of MRI, high-density electric source imaging (HD-ESI), SPECT and PET in epilepsy surgery candidates. Clin Neurophysiol. 2016 Jan;127(1):150-155. doi: 10.1016/j.clinph.2015.03.025. Epub 2015 May 9.</citation>
    <PMID>26021550</PMID>
  </reference>
  <reference>
    <citation>Mălîia MD, Meritam P, Scherg M, Fabricius M, Rubboli G, Mîndruţă I, Beniczky S. Epileptiform discharge propagation: Analyzing spikes from the onset to the peak. Clin Neurophysiol. 2016 Apr;127(4):2127-33. doi: 10.1016/j.clinph.2015.12.021. Epub 2016 Jan 12.</citation>
    <PMID>26818882</PMID>
  </reference>
  <reference>
    <citation>Mouthaan BE, Rados M, Barsi P, Boon P, Carmichael DW, Carrette E, Craiu D, Cross JH, Diehl B, Dimova P, Fabo D, Francione S, Gaskin V, Gil-Nagel A, Grigoreva E, Guekht A, Hirsch E, Hecimovic H, Helmstaedter C, Jung J, Kalviainen R, Kelemen A, Kimiskidis V, Kobulashvili T, Krsek P, Kuchukhidze G, Larsson PG, Leitinger M, Lossius MI, Luzin R, Malmgren K, Mameniskiene R, Marusic P, Metin B, Özkara C, Pecina H, Quesada CM, Rugg-Gunn F, Rydenhag B, Ryvlin P, Scholly J, Seeck M, Staack AM, Steinhoff BJ, Stepanov V, Tarta-Arsene O, Trinka E, Uzan M, Vogt VL, Vos SB, Vulliémoz S, Huiskamp G, Leijten FS, Van Eijsden P, Braun KP; E-PILEPSY consortium. Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe. Epilepsia. 2016 May;57(5):770-6. doi: 10.1111/epi.13347. Epub 2016 Mar 25.</citation>
    <PMID>27012361</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 30, 2019</study_first_submitted>
  <study_first_submitted_qc>January 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2020</study_first_posted>
  <last_update_submitted>January 11, 2020</last_update_submitted>
  <last_update_submitted_qc>January 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital</investigator_affiliation>
    <investigator_full_name>Sándor Beniczky</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Sensitivity</keyword>
  <keyword>Specificity</keyword>
  <keyword>Accuracy</keyword>
  <keyword>Automated ESI</keyword>
  <keyword>Refractory epilepsy</keyword>
  <keyword>Epilepsy surgery</keyword>
  <keyword>Clinical Utility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT04218812/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

